A new clue in lupus autoantibody production
12 April 2016 | By Victoria White, Digital Content Producer
Researchers have discovered that interferon gamma could hold the key to understanding how harmful autoantibodies form in lupus patients...
List view / Grid view
News
Regeneron and Intellia collaborate to discover CRISPR/Cas therapeutics
12 April 2016 | By Victoria White, Digital Content Producer
In addition to the discovery, development and commercialisation of new therapies, the companies will focus on technology development of the CRISPR/Cas platform...
New biomarkers for TB could lead to improved vaccines
12 April 2016 | By Victoria White, Digital Content Producer
A team of scientists have identified new biomarkers for TB which have shown for the first time why immunity from the widely used BCG vaccine is so variable...
Assessing the symptoms of post-Ebola syndrome to improve treatment
12 April 2016 | By Victoria White, Digital Content Producer
A study has assessed the effects of post-Ebola syndrome, that include vision complications, joint and muscle pain, and neurological problems, to improve treatments...
Genetic link confirmed between DCIS and development of invasive breast cancer
12 April 2016 | By Victoria White, Digital Content Producer
The discovery means that a family history of DCIS could be as important to assessing a woman’s risk as a history of invasive breast cancer...
Novel anti-diabetic drugs that can be controlled with light
11 April 2016 | By Victoria White, Digital Content Producer
New research could pave the way for a new generation of anti-diabetic drugs that are activated by the presence of either blue or ultra-violet light...
HIV vaccine candidate confirms promise in preclinical study
11 April 2016 | By Victoria White, Digital Content Producer
Mymetics’ HIV vaccine candidate generated significant protection in groups of twelve female monkeys against repeated AIDS virus exposures...
Drug candidates protect neurons against damage from amyloid-beta
11 April 2016 | By Victoria White, Digital Content Producer
Chemists have designed a set of molecules that promote microscopic, anatomical changes in neurons associated with the formation and retention of memories...
Nordic Nanovector and PSI team up to develop new ARCs for treating leukaemias
11 April 2016 | By Victoria White, Digital Content Producer
The collaboration aims to develop new antibody radionuclide conjugates (ARCs) optimised for the treatment of single cell leukaemias...
New set of genes associated with stroke identified
8 April 2016 | By Victoria White, Digital Content Producer
Researchers identified a new gene called FOXF2 which increased the risk of having a stroke due to small vessel disease in the brain...
Epiregulin identified as a possible target in lung cancer
8 April 2016 | By Victoria White, Digital Content Producer
A study found that in addition to decreased overall tumour burden, mice lacking epiregulin also showed reduced inflammation...
Cancers can resist treatment by ‘stealing’ blood vessels
8 April 2016 | By Victoria White, Digital Content Producer
A new study is the first to show that tumours can become resistant to drugs over time by learning to steal normal blood vessels from surrounding tissue...
Nanoparticles show promise for treating inflammatory bowel disease
8 April 2016 | By Victoria White
Nanoparticles designed to block a cell-surface molecule that plays a key role in inflammation could be a safe treatment for inflammatory bowel disease...
MRC Technology appoints two new members to its board of trustees
7 April 2016 | By Victoria White, Digital Content Producer
MRC Technology has appointed Dr Les Hughes and Dr Mike Romanos to the board of trustees, effective 1 March 2016...
Allergan signs $3.35 billion Alzheimer’s treatment deal with Heptares
7 April 2016 | By Victoria White, Digital Content Producer
Allergan is to license exclusive global rights to a broad portfolio of novel subtype-selective muscarinic receptor agonists in development by Heptares...
